Understanding the association between injecting and sexual risk behaviors of injecting drug users in Manipur and Nagaland, India

Harm Reduction Journal

Michelle Kermode³  Bidhubhusan Mahapatra²  Shrutika Sabarwal²  Niranjan Saggurti²  Chumben Humtsoe¹  Khrieketou Suohu¹ 

[1] Emmanuel Hospital Association, Project ORCHID, CIHSR 4th Mile, B Block, 2nd Floor, Dimapur, Nagaland, 797112, India;Population Council, New Delhi, India;Nossal Institute of Global Health, University Melbourne, Victoria, Australia

关键词: Northeastern India;    Condom use;    Sexual behavior;    Injecting drug users;   

Others  :  809935
DOI  :  10.1186/1477-7517-9-40

 received in 2012-08-21, accepted in 2012-12-14,  发布年份 2012

【 摘 要 】

Background

In India, as in rest of the world, HIV prevention programs have focused on HIV transmission through unsafe injecting practices with less attention on sexual risk behaviors among injecting drug users (IDUs). This study examines the sexual risk taking behaviors of IDUs associated with their pattern of drug use in India.

Methods

Data were obtained from the behavioral tracking survey conducted in 2009 among 1712 IDUs in two districts each of Manipur and Nagaland states in Northeastern part of India. Sexual risk behaviors among IDUs were assessed in terms of multiple sex partners, sex with a paid female partner in the last 12 months and inconsistent condom use with any female partner.

Results

More than one-fourth (27%) in Manipur and almost one in two (47%) IDUs reported having had sex with two or more female partners in the past 12 months. In Manipur where heroin is commonly used, the odds of having multiple sex partners were higher among non-heroin users than heroin users (42% vs. 23%, Adjusted Odds Ratio (AOR): 1.7, 95% Confidence Interval (CI): 1.1-2.6) and who shared needles/syringes in the last one month than who did not share (46% vs. 26%, AOR: 2.2, CI: 1.2-4.0). In Nagaland, where Spasmoproxyvon (SP, a synthetic opioid analgesic that contains dextropropoxyphene, dicyclomine hydrochloride and paracetamol) is most common, regular injectors as compared to occasional injectors were more likely to report multiple sex partners (67% vs. 42%, AOR: 2.7, CI: 1.8-4.1) and sex with paid partners (13% vs. 3%, AOR: 6.0, CI: 3.0-12.1). Sharing of needles/syringes was positively associated with multiple sex partners (51% vs. 44%, AOR: 1.6, CI: 1.2-2.2), and inconsistent condom use (93% vs. 80%, AOR: 3.0, CI: 1.8-5.1).

Conclusions

IDUs with unsafe injecting practices also engage in risky sexual practices magnifying the risk of HIV infection. There is a need to focus on prevention of sexual transmission among high-risk IDUs, particularly in areas where Spasmoproxyvon is commonly used.

【 授权许可】

   
2012 Suohu et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745.
• [2]Mahanta J, Medhi GK, Paranjape RS, Roy N, Kohli A, Akoijam BS, Dzuvichu B, Das HK, Goswami P, Thongamba G: Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS 2008, 22(Suppl 5):S59-S68.
• [3]Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, Detels R, Bhattacharya SK: Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian J Med Res 2000, 111:37-39.
• [4]Sarkar K, Bal B, Mukherjee R, Chakraborty S, Niyogi SK, Saha MK, Bhattacharya SK: Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh. Subst Use Misuse 2006, 41:341-352.
• [5]Devi KS, Singh NB, Mara J, Singh TB, Singh YM: Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injecting drug users in Manipur - a preliminary report. Indian J Med Microbiol 2004, 22:136-137.
• [6]Eicher AD, Crofts N, Benjamin S, Deutschmann P, Rodger AJ: A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India. AIDS Care 2000, 12:497-504.
• [7]Solomon SS, Srikrishnan AK, Mehta SH, Vasudevan CK, Murugavel KG, Thamburaj E, Anand S, Kumar MS, Latkin C, Solomon S, Celentano DD: High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr 2008, 49:327-332.
• [8]Aceijas C, Rhodes T: Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007, 18:352-358.
• [9]Aceijas C, Stimson GV, Hickman M, Rhodes T: Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004, 18:2295-2303.
• [10]Maher L, Chant K, Jalaludin B, Sargent P: Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia. J Gastroenterol Hepatol 2004, 19:1114-1120.
• [11]National AIDS Control Organisation (NACO): Strategy and implementation plan - national AIDS control programme phase III [2006–2011]. New Delhi, India: NACO, Department of AIDS control, Ministry of Health and Family Welfare, Government of India; 2006.
• [12]United Nations Office on Drugs and Crime (UNODC): South-east Asia opium survey 2011. Lao PDR, Myanmar: UNODC; 2011.
• [13]Chandrasekaran P, Dallabetta G, Loo V, Rao S, Gayle H, Alexander A: Containing HIV/AIDS in India: the unfinished agenda. Lancet Infect Dis 2006, 6:508-521.
• [14]Hangzo C, Chatterjee A, Sarkar S, Zomi GT, Deb BC, Abdul-Quader AS: Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India. Addiction 1997, 92:813-820.
• [15]Bill & Melinda Gates Foundation (BMGF): From hills to valleys: Avahan’s HIV prevention program among injecting drug users in Northeast India. New Delhi, India: BMGF; 2009.
• [16]Kumar MS, Mudaliar S, Daniels D: Community-based outreach HIV intervention for street-recruited drug users in Madras, India. Public Health Rep 1998, 113(Suppl 1):58-66.
• [17]Pisani E, Dadun , Sucahya PK, Kamil O, Jazan S: Sexual behavior among injection drug users in 3 indonesian cities carries a high potential for HIV spread to noninjectors. J Acquir Immune Defic Syndr 2003, 34:403-406.
• [18]Latkin C, Mandell W, Oziemkowska M, Vlahov D, Celentano D: The relationships between sexual behavior, alcohol use, and personal network characteristics among injecting drug users in Baltimore, Maryland. Sex Transm Dis 1994, 21:161-167.
• [19]Chikovani I, Bozicevic I, Goguadze K, Rukhadze N, Gotsadze G: Unsafe injection and sexual risk behavior among injecting drug users in Georgia. J Urban Health 2011, 88:736-748.
• [20]Strathdee SA, Sherman SG: The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health 2003, 80(4 Suppl 3):iii7-iii14.
• [21]Latkin CA, Mandell W, Vlahov D: The relationship between risk networks’ patterns of crack cocaine and alcohol consumption and HIV-related sexual behaviors among adult injection drug users: a prospective study. Drug Alcohol Depend 1996, 42:175-181.
• [22]United Nations Office on Drugs and Crime (UNODC): HIV prevention among young injecting drug users. New York, USA: UNODC; 2004.
• [23]Parry C, Carney T, Petersen P, Dewing S: Technical Report: Drug use and sexual HIV risk patterns among non-injecting and injecting drug users in Cape Town, Pretoria and Durban, South Africa. Cape Town, South Africa: Alcohol & Drug Abuse Research Unit, Medical Research Council; 2007.
• [24]Armstrong G, Humtsoe C, Kermode M: HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programme. BMC Publ Health 2011, 11(Suppl 6):S9. BioMed Central Full Text
• [25]Sarna A, Tun W, Bhattacharya A, Mahendra V, Selhore N, Singh A, Apicella L: Injecting drug users in India: Understanding sexual behaviours and sexual networks to design effective behaviour change strategies. New Delhi, India: Population Council; 2007.
• [26]Salganik M, Heckathorn D: Sampling and estimation in hidden populations using respondent-driven sampling. Sociol Methodol 2004, 34:193-240.
• [27]Malekinejad M, Johnston LG, Kendall C, Kerr LR, Rifkin MR, Rutherford GW: Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav 2008, 12(4 Suppl):S105-S130.
• [28]Saidel T, Adhikary R, Mainkar M, Dale J, Loo V, Rahman M, Ramesh BM, Paranjape RS: Baseline integrated behavioural and biological assessment among most at-risk populations in six high-prevalence states of India: design and implementation challenges. AIDS 2008, 22(Suppl 5):S17-S34.
• [29]Heckathorn D: Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl 2002, 49:11-34.
• [30]Gossop MR, Stern R, Connell PH: Drug dependence and sexual dysfunction: a comparison of intravenous users of narcotics and oral users of amphetamines. Br J Psychiatry 1974, 124:431-434.
• [31]Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW: Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav 2008, 12:S131-S141.
• [32]National AIDS Control Organisation (NACO): Annual report 2010–11. New Delhi, India: NACO, Department of AIDS Control, Ministry of Health and Family Welfare, Government of India; 2011.
• [33]Godbole S, Mehendale S: HIV/AIDS epidemic in India: risk factors, risk behaviour & strategies for prevention & control. Indian J Med Res 2005, 121:356-368.